Picture of 9 Meters Biopharma logo

NMTRQ 9 Meters Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Brief: 9 Meters Biopharma Inc Doses First Patients In Phase 1B/2A Clinical Trial In Short Bowel Syndrome

July 21 (Reuters) - 9 Meters Biopharma Inc  NMTR.O :
    * 9 METERS BIOPHARMA INC - DOSES FIRST PATIENTS IN PHASE
1B/2A
CLINICAL TRIAL IN SHORT BOWEL SYNDROME

Source: [ID:https://bit.ly/2E6gDYH]
Further company coverage:  NMTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on 9 Meters Biopharma

See all news